Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile



604 Fifth Avenue
Suite D
Redwood City  California  94063  U.S.A.
Phone: 650-216-3860 Fax: 650-299-1566


View Clinical Trials from BioPharm Insight

 Company News
Gynesonics Announces Another Peer-Reviewed Publication And Presentation Of Significant International Clinical Experience With VizAblate Technology For Symptomatic Uterine Fibroids 12/9/2014 2:12:53 PM
Gynesonics Receives FDA Approval To Commence A Pivotal IDE Clinical Trial For The Newly-Designed Vizablate® System 10/22/2014 12:39:38 PM
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization 8/7/2014 10:49:34 AM
Gynesonics Adds $6 Million For Fibroid Device 7/10/2014 6:57:40 AM
Gynesonics Announces First Patient Successfully Treated With Newly Designed Incisionless VizAblate® System For Symptomatic Uterine Fibroids 6/24/2014 10:21:49 AM
Gynesonics Receives CE Mark on Next Generation VizAblateĀ® System for the Treatment of Symptomatic Uterine Fibroids 6/12/2014 8:30:45 AM
Gynesonics Taps A New Chief Executive Officer 4/22/2014 9:30:30 AM
Gynesonics Completes $21 Million Series D Financing 2/20/2013 6:59:57 AM
Gynesonics Raises $5 Million in Funding 2/22/2012 7:38:04 AM
Gynesonics Announces the Start of the FAST-EU Study for the VizAblate(R) System 9/22/2011 9:36:57 AM